Citations (105)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Giulio Emilio Brancati, Donatella Acierno, Margherita Barbuti, Camilla Elefante, Samuele Gemignani, Accursio Raia & Giulio Perugi. (2023) Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD). Expert Review of Neurotherapeutics 23:11, pages 981-994.
Read now
Read now
Giulio Perugi, Alessandro Pallucchini, Salvatore Rizzato, Vito Pinzone & Pietro De Rossi. (2019) Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD). Expert Opinion on Pharmacotherapy 20:12, pages 1457-1470.
Read now
Read now
Ipek Suzer Gamli & Aysegul Yolga Tahiroglu. (2018) Six months methylphenidate treatment improves emotion dysregulation in adolescents with attention deficit/hyperactivity disorder: a prospective study. Neuropsychiatric Disease and Treatment 14, pages 1329-1337.
Read now
Read now
Ann C. Childress. (2016) Methylphenidate HCL for the treatment of ADHD in children and adolescents. Expert Opinion on Pharmacotherapy 17:8, pages 1171-1178.
Read now
Read now
Gil Zalsman & Tal Shilton. (2016) Adult ADHD: A new disease?. International Journal of Psychiatry in Clinical Practice 20:2, pages 70-76.
Read now
Read now
Giulio Perugi & Giulia Vannucchi. (2015) The use of stimulants and atomoxetine in adults with comorbid ADHD and bipolar disorder. Expert Opinion on Pharmacotherapy 16:14, pages 2193-2204.
Read now
Read now
Nicoletta Adamo, Sarah Seth & David Coghill. (2015) Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes. Expert Review of Clinical Pharmacology 8:4, pages 383-397.
Read now
Read now
Lisa L Weyandt, Danielle R Oster, Marisa E Marraccini, Bergljot Gyda Gudmundsdottir, Bailey A Munro, Brynheld Martinez Zavras & Ben Kuhar. (2014) Pharmacological interventions for adolescents and adults with ADHD: stimulant and nonstimulant medications and misuse of prescription stimulants. Psychology Research and Behavior Management 7, pages 223-249.
Read now
Read now
Philip Asherson, Allan H. Young, Dominique Eich-Höchli, Paul Moran, Vibeke Porsdal & Walter Deberdt. (2014) Differential diagnosis, comorbidity, and treatment of attention-deficit/hyperactivity disorder in relation to bipolar disorder or borderline personality disorder in adults. Current Medical Research and Opinion 30:8, pages 1657-1672.
Read now
Read now
Josep Antoni Ramos-Quiroga, Viviana Nasillo, Fernando Fernández-Aranda & Miguel Casas. (2014) Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults. Expert Review of Neurotherapeutics 14:5, pages 553-567.
Read now
Read now
Michael Rösler, Ylva Ginsberg, Torben Arngrim, Marios Adamou, Asko Niemelä, Joachim Dejonkheere, Joop van Oene & Barbara Schäuble. (2013) Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate. The World Journal of Biological Psychiatry 14:4, pages 282-290.
Read now
Read now
Wolfgang Retz, Rolf-Dieter Stieglitz, Salvatore Corbisiero, Petra Retz-Junginger & Michael Rösler. (2012) Emotional dysregulation in adult ADHD: what is the empirical evidence?. Expert Review of Neurotherapeutics 12:10, pages 1241-1251.
Read now
Read now
Wolfgang Retz, Michael Rösler, Claudia Ose, André Scherag, Barbara Alm, Alexandra Philipsen, Roland Fischer & Richard Ammer. (2012) Multiscale assessment of treatment efficacy in adults with ADHD: A randomized placebo-controlled, multi-centre study with extended-release methylphenidate. The World Journal of Biological Psychiatry 13:1, pages 48-59.
Read now
Read now
Timothy E Wilens, Nicholas R Morrison & Jefferson Prince. (2011) An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Review of Neurotherapeutics 11:10, pages 1443-1465.
Read now
Read now
Wolfgang Retz, Petra Retz-Junginger, Johannes Thome & Michael Rösler. (2011) Pharmacological treatment of adult ADHD in Europe. The World Journal of Biological Psychiatry 12:sup1, pages 89-94.
Read now
Read now
Articles from other publishers (90)
Siham Albesisi & Paul G. Overton. (2023) Relationship Between ADHD-Like Traits and Emotion Dysregulation in the Adult General Population. Advances in Neurodevelopmental Disorders.
Crossref
Crossref
Carlos López-Pinar, Benjamin Selaskowski, Niclas Braun, Victoria Fornés-Ferrer, Rebekka Euscher, Swantje Matthies, Thomas Jans, Ludger Tebartz van Elst, Christian Jacob, Michael Huss, Esther Sobanski, Wolfgang Retz, Michael Roesler, Petra Retz-Junginger, Barbara Alm, Bernhard Kis, Mona Abdel-Hamid, Michael Colla, Mathias Berger, Silke Lux & Alexandra Philipsen. (2023) Exploring the efficacy of dialectical behaviour therapy and methylphenidate on emotional comorbid symptoms in adults with attention Deficit/Hyperactivity disorder: Results of the COMPAS multicentre randomised controlled trial. Psychiatry Research 330, pages 115610.
Crossref
Crossref
Emilie Martz, Luisa Weiner & Sébastien Weibel. (2023) Identifying different patterns of emotion dysregulation in adult ADHD. Borderline Personality Disorder and Emotion Dysregulation 10:1.
Crossref
Crossref
Jame A. Agapoff, Zhang Chong, Matthew Meek & Gerrit I. van Schalkwyk. (2023) Pharmacologic and non-pharmacologic interventions for emotional lability: A meta-analysis. Neuroscience & Biobehavioral Reviews 149, pages 105184.
Crossref
Crossref
Craig B.H. Surman & Daniel M. Walsh. (2023) Do ADHD Treatments Improve Executive Behavior Beyond Core ADHD Symptoms in Adults? Evidence From Systematic Analysis of Clinical Trials. The Journal of Clinical Pharmacology 63:6, pages 640-653.
Crossref
Crossref
Craig B. H. Surman & Daniel M. Walsh. (2022) Do Treatments for Adult ADHD Improve Emotional Behavior? A Systematic Review and Analysis. Journal of Attention Disorders 26:14, pages 1822-1832.
Crossref
Crossref
Philip Asherson, Lena Johansson, Rachel Holland, Megan Bedding, Andrew Forrester, Laura Giannulli, Ylva Ginsberg, Sheila Howitt, Imogen Kretzschmar, Stephen Lawrie, Craig Marsh, Caroline Kelly, Megan Mansfield, Clare McCafferty, Khuram Khan, Ulrich Müller-Sedgwick, John Strang, Grace Williamson, Lauren Wilson, Susan Young, Sabine Landau & Lindsay Thomson. (2022) OROS-methylphenidate to reduce ADHD symptoms in male prisoners aged 16–25 years: a RCT. Efficacy and Mechanism Evaluation 9:6, pages 1-114.
Crossref
Crossref
Patrizia Ventura, Concetta de Giambattista, Paolo Trerotoli, Maddalena Cavone, Alessandra Di Gioia & Lucia Margari. (2022) Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study. Journal of Clinical Medicine 11:10, pages 2922.
Crossref
Crossref
Kim Boesen, Asger Sand Paludan-Müller, Peter C Gøtzsche & Karsten Juhl Jørgensen. (2022) Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. Cochrane Database of Systematic Reviews 2022:2.
Crossref
Crossref
Yoosuk An, Yoojin Song & Ung Gu Kang. (2022) A Conceptual Review on ADHD and Adult ADHD (2): Psychopathology, Diagnostic and Therapeutic Implications of ADHD. Journal of Korean Neuropsychiatric Association 61:2, pages 45.
Crossref
Crossref
Wolfgang Retz. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2465
2486
.
Michael Rösler, Wolfgang Retz & Daniel Turner. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
4543
4560
.
Douglas Teixeira Leffa, Arthur Caye & Luis Augusto Rohde. 2022. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder. New Discoveries in the Behavioral Neuroscience of Attention-Deficit Hyperactivity Disorder
1
18
.
Maayan Ben-Dor Cohen, Eran Eldar, Adina Maeir & Mor Nahum. (2021) Emotional dysregulation and health related quality of life in young adults with ADHD: a cross sectional study. Health and Quality of Life Outcomes 19:1.
Crossref
Crossref
Anja Plemenitaš Ilješ. 2021. ADHD - From Etiology to Comorbidity. ADHD - From Etiology to Comorbidity.
Tai-Ling Liu, Ray C. Hsiao, Wen-Jiun Chou & Cheng-Fang Yen. (2021) Self-Reported Depressive Symptoms and Suicidality in Adolescents with Attention-Deficit/Hyperactivity Disorder: Roles of Bullying Involvement, Frustration Intolerance, and Hostility. International Journal of Environmental Research and Public Health 18:15, pages 7829.
Crossref
Crossref
Tai-Ling Liu, Ray C. Hsiao, Wen-Jiun Chou & Cheng-Fang Yen. (2021) Perpetration of and Victimization in Cyberbullying and Traditional Bullying in Adolescents with Attention-Deficit/Hyperactivity Disorder: Roles of Impulsivity, Frustration Intolerance, and Hostility. International Journal of Environmental Research and Public Health 18:13, pages 6872.
Crossref
Crossref
Alessandro Pallucchini, Marco Carli, Angelo Maremmani, Marco Scarselli, Giulio Perugi & Icro Maremmani. (2021) Influence of Substance Use Disorder on Treatment Retention of Adult-Attention-Deficit/Hyperactive Disorder Patients. A 5-Year Follow-Up Study. Journal of Clinical Medicine 10:9, pages 1984.
Crossref
Crossref
Wolfgang Retz. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
23
.
Michael Rösler, Wolfgang Retz & Daniel Turner. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
18
.
Ashkan Beheshti, Mira-Lynn Chavanon & Hanna Christiansen. (2020) Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis. BMC Psychiatry 20:1.
Crossref
Crossref
W. Retz, P. Retz-Junginger, S. Davydenko & M. Rösler. (2020) Medikamentöse Therapie der Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im ErwachsenenalterPharmacotherapy of attention deficit hyperactivity disorder in adults. Der Nervenarzt 91:7, pages 583-590.
Crossref
Crossref
Elisabet Kvadsheim, Ole Bernt Fasmer, Berge Osnes, Julian Koenig, Steinunn Adolfsdottir, Heike Eichele, Kerstin Jessica Plessen & Lin Sørensen. (2020) Lower Cardiac Vagal Activity Predicts Self-Reported Difficulties With Emotion Regulation in Adolescents With ADHD. Frontiers in Psychiatry 11.
Crossref
Crossref
Mariya V. Cherkasova, Lisa R. French, Cassidy A. Syer, Lorne Cousins, Harry Galina, Yasaman Ahmadi-Kashani & Lily Hechtman. (2016) Efficacy of Cognitive Behavioral Therapy With and Without Medication for Adults With ADHD: A Randomized Clinical Trial. Journal of Attention Disorders 24:6, pages 889-903.
Crossref
Crossref
Michael Rösler & Wolfgang Retz. (2020) Medikamentöse Therapie der ADHS bei Erwachsenen. PSYCH up2date 14:01, pages 59-75.
Crossref
Crossref
Stefano Pallanti & Luana SalernoStefano Pallanti & Luana Salerno. 2020. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders
61
86
.
Stefano Pallanti & Luana SalernoStefano Pallanti & Luana Salerno. 2020. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders
33
43
.
Philip Asherson, Lena Johansson, Rachel Holland, Tom Fahy, Andrew Forester, Sheila Howitt, Stephen Lawrie, John Strang, Susan Young, Sabine Landau & Lindsay Thomson. (2019) Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II). Trials 20:1.
Crossref
Crossref
Laura Gisbert, Vanesa Richarte, Montserrat Corrales, Pol Ibáñez, Rosa Bosch, Mariano Bellina, Christian Fadeuilhe, Miquel Casas & Josep Antoni Ramos-Quiroga. (2018) The Relationship Between Neuropsychological Deficits and Emotional Lability in Adults With ADHD. Journal of Attention Disorders 23:12, pages 1514-1525.
Crossref
Crossref
Alexandra Sebastian, Wolfgang Retz, Oliver Tüscher & Daniel Turner. (2019) Violent offending in borderline personality disorder and attention deficit/hyperactivity disorder. Neuropharmacology 156, pages 107565.
Crossref
Crossref
Michael J. Silverstein, Stephen V. Faraone, Samuel Alperin, Terry L. Leon, Joseph Biederman, Thomas J. Spencer & Lenard A. Adler. (2018) Validation of the Expanded Versions of the Adult ADHD Self-Report Scale v1.1 Symptom Checklist and the Adult ADHD Investigator Symptom Rating Scale. Journal of Attention Disorders 23:10, pages 1101-1110.
Crossref
Crossref
Doug Hyun Han, David McDuff, Donald Thompson, Mary E Hitchcock, Claudia L Reardon & Brian Hainline. (2019) Attention-deficit/hyperactivity disorder in elite athletes: a narrative review. British Journal of Sports Medicine 53:12, pages 741-745.
Crossref
Crossref
Yuyang Luo, Dana Weibman, Jeffrey M. Halperin & Xiaobo Li. (2019) A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD). Frontiers in Human Neuroscience 13.
Crossref
Crossref
Stephen V. Faraone, Anthony L. Rostain, Joseph Blader, Betsy Busch, Ann C. Childress, Daniel F. Connor & Jeffrey H. Newcorn. (2019) Practitioner Review: Emotional dysregulation in attention-deficit/hyperactivity disorder - implications for clinical recognition and intervention. Journal of Child Psychology and Psychiatry 60:2, pages 133-150.
Crossref
Crossref
Christoforos Iraklis Giakoumatos & David Osser. (2019) The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Unipolar Nonpsychotic Depression. Harvard Review of Psychiatry 27:1, pages 33-52.
Crossref
Crossref
Talar R. Moukhtarian, Ruth S. Mintah, Paul Moran & Philip Asherson. (2018) Emotion dysregulation in attention-deficit/hyperactivity disorder and borderline personality disorder. Borderline Personality Disorder and Emotion Dysregulation 5:1.
Crossref
Crossref
Lenard A. Adler & Michael J. Silverstein. (2018) Emotional Dysregulation in Adult ADHD. Psychiatric Annals 48:7, pages 318-322.
Crossref
Crossref
Anna Shushakova, Patricia Ohrmann & Anya Pedersen. (2017) Exploring deficient emotion regulation in adult ADHD: electrophysiological evidence. European Archives of Psychiatry and Clinical Neuroscience 268:4, pages 359-371.
Crossref
Crossref
Laura Gisbert, Vanesa Richarte, Montserrat Corrales, Pol Ibáñez, Rosa Bosch, Miquel Casas & Josep Antoni Ramos-Quiroga. (2017) The Impact of Emotional Lability Symptoms During Childhood in Adults With ADHD. Journal of Attention Disorders 22:6, pages 581-590.
Crossref
Crossref
Francesca Lenzi, Samuele Cortese, Joseph Harris & Gabriele Masi. (2018) Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 84, pages 359-367.
Crossref
Crossref
W. Burleson Daviss & Joseph Bond. 2018. Moodiness in ADHD. Moodiness in ADHD
5
23
.
Michael J. Silverstein, Samuel Alperin, Yonatan Hochstein & Lenard A. Adler. 2018. Moodiness in ADHD. Moodiness in ADHD
161
185
.
Martin A. Katzman, Timothy S. Bilkey, Pratap R. Chokka, Angelo Fallu & Larry J Klassen. (2017) Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry 17:1.
Crossref
Crossref
Frederick W. Reimherr, Barrie K. Marchant, Thomas E. Gift & Tammy A. Steans. (2017) ADHD and Anxiety: Clinical Significance and Treatment Implications. Current Psychiatry Reports 19:12.
Crossref
Crossref
Elke Riechmann, Frank A. Sattler, Hanna Christiansen & Mira-Lynn Chavanon. (2017) Emotionsregulation. Lernen und Lernstörungen 6:3, pages 145-155.
Crossref
Crossref
T.R. Moukhtarian, R.E. Cooper, E. Vassos, P. Moran & P. Asherson. (2020) Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis. European Psychiatry 44, pages 198-207.
Crossref
Crossref
Sevginar Vatan. (2017) Duygular ve Psikolojik Belirtiler Arasındaki İlişkiler. Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry 9:1, pages 45-45.
Crossref
Crossref
Esther Sobanski, Barbara Alm & Johannes Thome. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
2585
2621
.
Salvatore Corbisiero, Beatrice Mörstedt, Hannes Bitto & Rolf-Dieter Stieglitz. (2017) Emotional Dysregulation in Adults With Attention-Deficit/Hyperactivity Disorder-Validity, Predictability, Severity, and Comorbidity. Journal of Clinical Psychology 73:1, pages 99-112.
Crossref
Crossref
Annette Conzelmann, Eva Woidich, Ronald F. Mucha, Peter Weyers, Mathias Müller, Klaus-Peter Lesch, Christian P. Jacob & Paul Pauli. (2016) Methylphenidate and emotional-motivational processing in attention-deficit/hyperactivity disorder. Journal of Neural Transmission 123:8, pages 971-979.
Crossref
Crossref
J.A. Ramos-Quiroga, M. Corominas-Roso, G. Palomar, R. Ferrer, S. Valero, M. Corrales, V. Richarte & M. Casas. (2016) Cortisol awakening response in adults with attention deficit hyperactivity disorder: Subtype differences and association with the emotional lability. European Neuropsychopharmacology 26:7, pages 1140-1149.
Crossref
Crossref
Philip Asherson, Jan Buitelaar, Stephen V Faraone & Luis A Rohde. (2016) Adult attention-deficit hyperactivity disorder: key conceptual issues. The Lancet Psychiatry 3:6, pages 568-578.
Crossref
Crossref
Beatrice Mörstedt, Salvatore Corbisiero, Hannes Bitto & Rolf-Dieter Stieglitz. (2015) Emotional symptoms and their contribution to functional impairment in adults with attention-deficit/hyperactivity disorder. ADHD Attention Deficit and Hyperactivity Disorders 8:1, pages 21-33.
Crossref
Crossref
Mats Fredriksen & Dawn E. Peleikis. (2016) Long-Term Pharmacotherapy of Adults With Attention Deficit Hyperactivity Disorder: A Literature Review and Clinical Study. Basic & Clinical Pharmacology & Toxicology 118:1, pages 23-31.
Crossref
Crossref
T Cadman, J. Findon, H. Eklund, H. Hayward, D. Howley, C. Cheung, J. Kuntsi, K. Glaser, D. Murphy & P. Asherson. (2020) Six-year follow-up study of combined type ADHD from childhood to young adulthood: Predictors of functional impairment and comorbid symptoms. European Psychiatry 35, pages 47-54.
Crossref
Crossref
Argelinda Baroni & F Xavier Castellanos. (2015) Stimulants, cognition and ADHD. Current Opinion in Behavioral Sciences 4, pages 109-114.
Crossref
Crossref
Ann C. Childress & Floyd R. Sallee. (2015) Emotional Lability in Patients with Attention-Deficit/Hyperactivity Disorder: Impact of Pharmacotherapy. CNS Drugs 29:8, pages 683-693.
Crossref
Crossref
P. Asherson, S. Stes, M. Nilsson Markhed, L. Berggren, P. Svanborg, A. Kutzelnigg & W. Deberdt. (2020) The effects of atomoxetine on emotional control in adults with ADHD: An integrated analysis of multicenter studies. European Psychiatry 30:4, pages 511-520.
Crossref
Crossref
AliceAnn Crandall, Kirby Deater-Deckard & Anne W. Riley. (2015) Maternal emotion and cognitive control capacities and parenting: A conceptual framework. Developmental Review 36, pages 105-126.
Crossref
Crossref
Fred W. Reimherr, Barrie K. Marchant, Thomas E. Gift, Tammy A. Steans & Paul H. Wender. (2015) Types of adult attention-deficit hyperactivity disorder (ADHD): baseline characteristics, initial response, and long-term response to treatment with methylphenidate. ADHD Attention Deficit and Hyperactivity Disorders 7:2, pages 115-128.
Crossref
Crossref
T. Villemonteix, D. Purper-Ouakil & L. Romo. (2015) La dysrégulation émotionnelle est-elle une des composantes du trouble déficit d’attention/hyperactivité ?. L'Encéphale 41:2, pages 108-114.
Crossref
Crossref
Caroline Skirrow, Grainne McLoughlin, Tobias Banaschewski, Daniel Brandeis, Jonna Kuntsi & Philip Asherson. (2015) Normalisation of frontal theta activity following methylphenidate treatment in adult attention-deficit/hyperactivity disorder. European Neuropsychopharmacology 25:1, pages 85-94.
Crossref
Crossref
Esther Sobanski, Barbara Alm & Johannes Thome. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
38
.
Eugenia Sinita & David Coghill. (2014) The use of stimulant medications for non-core aspects of ADHD and in other disorders. Neuropharmacology 87, pages 161-172.
Crossref
Crossref
Mats Fredriksen, Alv A. Dahl, Egil W. Martinsen, Ole Klungsøyr, Jan Haavik & Dawn E. Peleikis. (2014) Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): An open-label prospective study of time in treatment, dose, side-effects and comorbidity. European Neuropsychopharmacology 24:12, pages 1873-1884.
Crossref
Crossref
J. Russell Ramsay & Anthony L. Rostain. 2015. Attention-Deficit Hyperactivity Disorder in Adults and Children. Attention-Deficit Hyperactivity Disorder in Adults and Children
366
377
.
Wolfgang Retz & Petra Retz-Junginger. (2014) Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD). European Archives of Psychiatry and Clinical Neuroscience 264:S1, pages 35-43.
Crossref
Crossref
Raquel Vidal, Sergi Valero, Mariana Nogueira, Gloria Palomar, Montse Corrales, Vanesa Richarte, Rosa Bosch, Nuria Gómez-Barros, Margarida Corominas, Miguel Casas & Josep Antoni Ramos-Quiroga. (2014) Emotional lability: The discriminative value in the diagnosis of attention deficit/hyperactivity disorder in adults. Comprehensive Psychiatry 55:7, pages 1712-1719.
Crossref
Crossref
Jonathan Posner, Erica Kass & Leslie Hulvershorn. (2014) Using Stimulants to Treat ADHD-Related Emotional Lability. Current Psychiatry Reports 16:10.
Crossref
Crossref
Maria Unenge Hallerbäck, Tove Lugnegård & Christopher Gillberg. (2012) ADHD and Nicotine Use in Schizophrenia or Asperger Syndrome. Journal of Attention Disorders 18:5, pages 425-433.
Crossref
Crossref
E. Sobanski, W. Retz, R. Fischer, C. Ose, B. Alm, O. Hennig & M. Rösler. (2020) Treatment adherence and persistence in adult ADHD: Results from a twenty-four week controlled clinical trial with extended release methylphenidate. European Psychiatry 29:5, pages 324-330.
Crossref
Crossref
Diane Purper-Ouakil, Cécile Vacher & Thomas Villemonteix. (2014) Trouble déficit d’attention/hyperactivité (TDA/H) et émotions : de la labilité émotionnelle au trouble bipolaire. Annales Médico-psychologiques, revue psychiatrique 172:4, pages 309-312.
Crossref
Crossref
H. Javelot, C. Glay-Ribau, F. Ligier, L. Weiner, N. Didelot, M. Messaoudi, M. Socha, F. Body-Lawson & B. Kabuth. (2014) Methylphenidate–risperidone combination in child psychiatry: A retrospective analysis of 44 cases. Annales Pharmaceutiques Françaises 72:3, pages 164-177.
Crossref
Crossref
Blanca Bolea-Alamañac, David J Nutt, Marios Adamou, Phillip Asherson, Stephen Bazire, David Coghill, David Heal, Ulrich Müller, John Nash, Paramala Santosh, Kapil Sayal, Edmund Sonuga-Barke & Susan J Young. (2014) Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 28:3, pages 179-203.
Crossref
Crossref
Philip Asherson, Iris Manor & Michael Huss. (2014) Attention-deficit/hyperactivity disorder in adults: update on clinical presentation and care. Neuropsychiatry 4:1, pages 109-128.
Crossref
Crossref
Andrew Merwood, Wai Chen, Fruhling Rijsdijk, Caroline Skirrow, Henrik Larsson, Anita Thapar, Jonna Kuntsi & Philip Asherson. (2014) Genetic Associations Between the Symptoms of Attention-Deficit/Hyperactivity Disorder and Emotional Lability in Child and Adolescent Twins. Journal of the American Academy of Child & Adolescent Psychiatry 53:2, pages 209-220.e4.
Crossref
Crossref
Craig B. H. Surman, Joseph Biederman, Thomas Spencer, Carolyn A. Miller, Katie M. McDermott & Stephen V. Faraone. (2013) Understanding deficient emotional self-regulation in adults with attention deficit hyperactivity disorder: a controlled study. ADHD Attention Deficit and Hyperactivity Disorders 5:3, pages 273-281.
Crossref
Crossref
G. Perugi, G. Ceraudo, G. Vannucchi, S. Rizzato, C. Toni & L. Dell'Osso. (2013) Attention Deficit/Hyperactivity Disorder symptoms in Italian bipolar adult patients: A preliminary report. Journal of Affective Disorders 149:1-3, pages 430-434.
Crossref
Crossref
Mats Fredriksen, Anne Halmøy, Stephen V. Faraone & Jan Haavik. (2013) Long-term efficacy and safety of treatment with stimulants and atomoxetine in adult ADHD: A review of controlled and naturalistic studies. European Neuropsychopharmacology 23:6, pages 508-527.
Crossref
Crossref
Salvatore Corbisiero, Rolf-Dieter Stieglitz, Wolfgang Retz & Michael Rösler. (2012) Is emotional dysregulation part of the psychopathology of ADHD in adults?. ADHD Attention Deficit and Hyperactivity Disorders 5:2, pages 83-92.
Crossref
Crossref
Caroline Skirrow & Philip Asherson. (2013) Emotional lability, comorbidity and impairment in adults with attention-deficit hyperactivity disorder. Journal of Affective Disorders 147:1-3, pages 80-86.
Crossref
Crossref
Fernanda Valle Krieger, Ellen Leibenluft, Argyris Stringaris & Guilherme V. Polanczyk. (2013) Irritability in children and adolescents: past concepts, current debates, and future opportunities. Revista Brasileira de Psiquiatria 35:suppl 1, pages S32-S39.
Crossref
Crossref
. 2013. Handbook for Attention Deficit Hyperactivity Disorder in Adults. Handbook for Attention Deficit Hyperactivity Disorder in Adults
65
85
.
Esther Sobanski, Georgios Paslakis, Michael Schredl, Stephanie Daffner & Barbara Alm. 2013. ADHD in Adults. ADHD in Adults
137
154
.
Philip Asherson. 2013. ADHD in Adults. ADHD in Adults
1
17
.
Caroline Skirrow, Georgina M. Hosang, Anne E. Farmer & Philip Asherson. (2012) An update on the debated association between ADHD and bipolar disorder across the lifespan. Journal of Affective Disorders 141:2-3, pages 143-159.
Crossref
Crossref
Michael Colla. 2012. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie
1111
1119
.
Barrie K. Marchant, Fred W. Reimherr, Corinne Halls, Erika D. Williams, Robert E. Strong, Douglas Kondo, Poonam Soni & Reid J. Robison. (2011) Long-term open-label response to atomoxetine in adult ADHD: influence of sex, emotional dysregulation, and double-blind response to atomoxetine. ADHD Attention Deficit and Hyperactivity Disorders 3:3, pages 237-244.
Crossref
Crossref
Yu-Shu Huang & Ming-Horng Tsai. (2011) Long-Term Outcomes with Medications for Attention-Deficit Hyperactivity Disorder. CNS Drugs 25:7, pages 539-554.
Crossref
Crossref
Martin J. Herrmann, Stefanie C. Biehl, Christian Jacob & Jürgen Deckert. (2010) Neurobiological and psychophysiological correlates of emotional dysregulation in ADHD patients. ADHD Attention Deficit and Hyperactivity Disorders 2:4, pages 233-239.
Crossref
Crossref